No Benefit from Chest Wall Irradiation in Intermediate-Risk Breast ...
Dec 15, 2024 · PATIENTS with intermediate-risk breast cancer demonstrate comparable 10-year overall survival rates, irrespective of chest wall irradiation (CWI) following mastectomy, as shown in findings from the BIG 2-04 MRC SUPREMO trial.
May 2, 2024 · Abbreviations: AML: acute myeloid leukemia; CCUS: clonal cytopenia of undetermined significance; del: deletion; EB: excess blasts; FISH: fluorescence in situ ...
Novel Approaches to Treat Glioblastoma Multiforme
Oct 29, 2024 · Disclosure: The authors have declared no conflicts of interest. Received: 24.07.24 Accepted: 27.09.24 Citation:
Why EGFR Exon 21 L858R Mutations Should Be Treated Differently
BACKGROUND. EGFR gene mutations have been reported in 15–60% of non-small cell lung cancers (NSCLCs) with an important difference in prevalence between Eastern and Western populations. 1,2 The most common EGFR-activating mutations in NSCLC include in-frame deletions in exon 19 and a substitution in exon 21 (L858R) which account for 47% and 41%, respectively, of observed EGFR mutations in ...
EMJ | Elevating the quality of healthcare globally
Data from 22 studies, encompassing 756,088 subjects, including 62,072 Hispanic adults, revealed striking findings.
Xpert-Ultra Enhances Tuberculosis Diagnosis and Risk Stratification
2 days ago · A RECENT study highlights the clinical impact of Xpert MTB/RIF Ultra (Xpert-Ultra) in improving tuberculosis (TB) diagnosis and assessing transmission risk in low-burden settings like the UK. The research, conducted at University Hospitals of Leicester NHS Trust, evaluated the real-world utility of ...
Asthma Outcomes Improve with Specialist Allergy Treatment
2 days ago · CHILDREN with asthma enrolled in Arkansas Medicaid who received allergy specialist care had a 21% lower likelihood of experiencing asthma-related adverse events (AAEs) compared to those who did not.. Asthma is a common chronic condition in children, frequently requiring specialised care to manage symptoms and prevent exacerbations.
New CML Treatment Shows Promise, But Standard Therapy Endures
Oct 18, 2024 · The ASC4FIRST trial has shown asciminib, a novel BCR::ABL1 inhibitor, as a promising alternative to current tyrosine kinase inhibitors (TKIs) for chronic phase (CP) chronic myeloid leukaemia (CML). However, experts caution that the study’s design and outcomes raise significant questions, suggesting that imatinib, the original …
Current Trends in Pediatric Cosmetic Treatments - AMJ
Dec 28, 2024 · IN RECENT years, there has been a noticeable increase in cosmetic treatments among pediatric populations, reflecting a shift from the traditional focus on adult patients. This trend has spurred greater interest in aesthetic dermatologic procedures aimed at addressing various skin conditions in ...
Processed Red Meat Increases Risk of Dementia by 13% - EMJ
2 days ago · CONSUMING processed red meat daily raises dementia risk by 13%, new research has shown, with potential cognitive benefits from replacing it with nuts, legumes, or fish. A large-scale, long-term study involving 133,771 participants investigated the link between red meat consumption and dementia ...